This brand name is authorized in Spain
The drug FERBISOL contains one active pharmaceutical ingredient (API):
|
1
Ferrous glycine sulfate
UNII 56PS9HY5XI - FERROUS GLYCINE SULFATE
|
|
Ferrous glycine sulfate is a medicinal product for the treatment of iron deficiency. It contains iron (Fe2+) in a form that the body can easily absorb and utilize and is therefore suitable to eliminate symptoms caused by iron deficiency. Like all iron preparations, ferrous glycine sulfate has no effects on erythropoiesis or anaemia that is not due to iron deficiency. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B03AA01 | Ferrous glycine sulfate | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AA Iron bivalent, oral preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 66867 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
